n. 3, September 2018
![]() ![]() DO NOT MISS THIS EDUCATIONAL EVENT Clock is ticking for the very interesting and clinically relevant upcoming full-day EuDial educational meeting 'Haemodialysis Update 2018: from basics to advances in the treatment of CKD' to be held at the Annual Meeting of the Italian Society of Nephrology (Società Italiana di Nefrologia – SIN), in Rimini (Italy) on October 3, 2018.
Click here to download the final programme.
Book your place for free at www.sin2018.it (select EUDIAL course)
![]() ![]() Keen in getting involved in Incremental Haemodialysis? Why not taking the survey created by Prof. C. Basile (EUDIAL Chair) - it is available here.
The majority of patients on dialysis are currently treated with a fixed dose thrice-weekly haemodialysis regimen irrespective of whether or not they are starting dialysis therapy (incident) or have been receiving dialysis for some time (prevalent) and without consideration for their residual kidney function (RKF). The thrice-weekly regimen has been assumed almost as a dogma in the dialysis community. Incredibly, this schedule has been widely accepted worldwide without ever undergoing any randomised controlled trial to examine whether less frequent haemodialysis treatments would be inadequate or harmful. ![]() ![]() The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If you wish to unsubscribe from this newsletter please reply this email and specify ‘unsubscribe’. |